<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02910206</url>
  </required_header>
  <id_info>
    <org_study_id>XJH-A-2015-12-01</org_study_id>
    <nct_id>NCT02910206</nct_id>
  </id_info>
  <brief_title>Etomidate to Improve Outcome in Elderly Patients</brief_title>
  <acronym>EPO</acronym>
  <official_title>Comparative Efficacy and Safety of Etomidate or Propofol in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhihong LU</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elderly patients have high mortality and postoperative complications rate after surgery,
      especially postoperative cardiac complications. A meta-analysis revealed haemodynamic
      intraoperative events significantly increased the risk of postoperative cardiac
      complications.To limit the risk, optimize the intraoperative management of circulation is
      essential. Anesthetic drug may effect on the haemodynamic intraoperative, reduction of
      postoperative complications should aimed at choosing the optimal anesthetic drug with minimal
      effect on haemodynamic.So this study is to explore the comparative efficacy and safety of
      anesthetic drug (etomidate or propofol) in elderly patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with complications defined by ICD (International codes of diseases)-9</measure>
    <time_frame>From the moment of giving sufentanil to the moment of discharge from hospital,up to 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the time of recovery from anesthesia</measure>
    <time_frame>From stopping etomidate or propofol infusion to awake,approximately 30min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Nausea And vomiting score</measure>
    <time_frame>24 hour, 48 hour and 72 hour after extubation，approximately 24 hour, 48 hour and 72 hour respectively</time_frame>
    <description>score:0,no nausea and vomiting; 1,nausea without vomiting; 2,vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain on visual analogue scale</measure>
    <time_frame>24 hours, 48 hours and 72 hours after extubation，approximately 24 hour, 48 hour and 72 hour respectively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of serum Cortisol by radioimmunoassay</measure>
    <time_frame>24hours,48hours and 72hours after extubation，approximately 24 hour, 48 hour and 72 hour respectively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of serum aldosterone by radioimmunoassay</measure>
    <time_frame>24hours,48hours and 72hours after extubation，approximately 24 hour, 48 hour and 72 hour respectively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of serum Adrenocorticotropichormone(ACTH) by radioimmunoassay</measure>
    <time_frame>24hours,48hours and 72hours after extubation，approximately 24 hour, 48 hour and 72 hour respectively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2100</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>etomidate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>etomidate is given for maintenance of general anesthesia,combined with sufentanil and cisatracurium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol is given for maintenance of general anesthesia,combined with sufentanil and cisatracurium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate</intervention_name>
    <description>etomidate is given intravenously</description>
    <arm_group_label>etomidate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol is given intravenously</description>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil</intervention_name>
    <description>sufentanil is given intravenously</description>
    <arm_group_label>etomidate</arm_group_label>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisatracurium</intervention_name>
    <description>Cisatracurium is given intravenously</description>
    <arm_group_label>etomidate</arm_group_label>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 65 and 80 years old.

          -  Patients who received laparoscopic gastrointestinal surgery under general
             anesthesia,expected duration of surgery between 1 and 4 hour.

          -  American Society of Anesthesiologists class I to III.

          -  Body Mass Index between 18 and 25 kg/m2.

          -  Patients who signed written informed consent

        Exclusion Criteria:

          -  Cerebrovascular accident occurred within the previous 3 months,such as stroke or
             transient ischemic attack

          -  Patients with serious hepatic dysfunction ( the serum level of alanine transaminase,
             conjugated bilirubin, aspartate transaminase, alkaline phosphatase or total bilirubin
             is 2 folds more than upper normal limit) or renal dysfunction(creatinine clearance
             rate less than 30 milliliter per minute).

          -  Diabetic patients with complication (diabetic ketoacidosis, hyperosmotic coma,all
             kinds of infection, macroangiopathy, diabetic nephropathy, retinopathy, diabetic
             cardiomyopathy, diabetic neuropathy, diabetic foot).

          -  Unstable angina and myocardial infarction occurred within the previous 3 months

          -  Preoperative blood pressure more than or equal to 180/110 mmHg

          -  Confirmed or suspected of narcotic analgesics abusing or long term using

          -  Taken corticosteroids or immunosuppressive agents for more than 10 days with the
             previous 6 months or had history of adrenal suppression or immune system disease.

          -  Patients with thyroid hypofunction.

          -  Patients with history of asthma.

          -  Patients with history of surgery within previous 3 months.

          -  Patients allergic or contraindicated to propofol or etomidate

          -  Patients participated in other study within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lize Xiong, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Xijing hosptial</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hailong Dong, PhD</last_name>
    <phone>86-29-84775337</phone>
    <email>hldong6@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lize XIONG, MD</last_name>
      <phone>86-29-84775001</phone>
      <email>mzkxlz@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhihong LU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Du Y, Chen YJ, He B, Wang YW. The Effects of Single-Dose Etomidate Versus Propofol on Cortisol Levels in Pediatric Patients Undergoing Urologic Surgery: A Randomized Controlled Trial. Anesth Analg. 2015 Dec;121(6):1580-5. doi: 10.1213/ANE.0000000000000981.</citation>
    <PMID>26496368</PMID>
  </reference>
  <reference>
    <citation>Aghdaii N, Ziyaeifard M, Faritus SZ, Azarfarin R. Hemodynamic Responses to Two Different Anesthesia Regimens in Compromised Left Ventricular Function Patients Undergoing Coronary Artery Bypass Graft Surgery: Etomidate-Midazolam Versus Propofol-Ketamine. Anesth Pain Med. 2015 Jun 22;5(3):e27966. doi: 10.5812/aapm.27966v2. eCollection 2015 Jun.</citation>
    <PMID>26161330</PMID>
  </reference>
  <reference>
    <citation>Song JC, Lu ZJ, Jiao YF, Yang B, Gao H, Zhang J, Yu WF. Etomidate Anesthesia during ERCP Caused More Stable Haemodynamic Responses Compared with Propofol: A Randomized Clinical Trial. Int J Med Sci. 2015 Jul 3;12(7):559-65. doi: 10.7150/ijms.11521. eCollection 2015.</citation>
    <PMID>26180512</PMID>
  </reference>
  <reference>
    <citation>Kaushal RP, Vatal A, Pathak R. Effect of etomidate and propofol induction on hemodynamic and endocrine response in patients undergoing coronary artery bypass grafting/mitral valve and aortic valve replacement surgery on cardiopulmonary bypass. Ann Card Anaesth. 2015 Apr-Jun;18(2):172-8. doi: 10.4103/0971-9784.154470.</citation>
    <PMID>25849685</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2016</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Zhihong LU</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>etomidate</keyword>
  <keyword>propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Cisatracurium</mesh_term>
    <mesh_term>Atracurium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

